Ignite Creation Date:
2025-12-25 @ 12:33 AM
Ignite Modification Date:
2026-01-16 @ 6:42 AM
Study NCT ID:
NCT05809167
Status:
RECRUITING
Last Update Posted:
2023-04-12
First Post:
2023-02-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Venetoclax+Azacytidine+Modified BUCY Conditioning Regimen for Acute Lymphoblastic Leukemia Undergoing Allo-HSCT
Sponsor:
The First Affiliated Hospital of Soochow University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-01-20
Start Date Type:
ACTUAL
Primary Completion Date:
2025-01-20
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-01-20
Completion Date Type:
ESTIMATED
First Submit Date:
2023-02-27
First Submit QC Date:
None
Study First Post Date:
2023-04-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-04-10
Last Update Post Date:
2023-04-12
Last Update Post Date Type:
ACTUAL